Ocugen

Ocugen Announces Publication of a Comprehensive Review of BBV152 in Frontiers in Immunology

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced the publication of “A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects” which appeared in Frontiers in Immunology. BBV152, commercialized …

Ocugen Announces Publication of a Comprehensive Review of BBV152 in Frontiers in Immunology Read More

Vaccines

HHS Announces Additional Deliveries of Vaccine as Part of Nationwide Vaccine Strategy for Preventing Monkeypox

WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) announced that it recently began delivering additional doses of vaccine as part of an enhanced nationwide vaccination strategy …

HHS Announces Additional Deliveries of Vaccine as Part of Nationwide Vaccine Strategy for Preventing Monkeypox Read More

COVID-19 vaccine

Biden-Harris Administration Secures 105 Million Doses of Pfizer’s Latest COVID-19 Vaccine for Fall Vaccination Campaign

WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense, announced a recent agreement to purchase 105 million doses of Pfizer’s COVID-19 …

Biden-Harris Administration Secures 105 Million Doses of Pfizer’s Latest COVID-19 Vaccine for Fall Vaccination Campaign Read More